Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NmVac4-A/C/Y/W-135-DT vs Licensed Vaccine in Adults
NCT01897402Phase 2Completed
- Sponsor
- JN-International Medical Corporation
- Start
- Jul 2013
- Primary completion
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NmVac4-A/C/Y/W-135-DT in meningococcal meningitis, sponsored by JN-International Medical Corporation. Started Jul 2013; status: completed.
02
Drugs
NmVac4-A/C/Y/W-135-DT
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT01897402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897402.